
If Russia carries out its threat of shutting off gas flows to the west, Danish pharmaceutical firm Novo Nordisk has a backup plan at the ready.
Mitigating the consequences of a gas shortage would be important for the company’s continued production of essential medicines, said Novo Nordisk’s chief financial officer, Karsten Munk Knudsen, at a teleconference in connection with the firm’s recently published H1 report.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app